The doors are open at BIOAsiaTaiwan! Swing by booth M332 to meet the TaiMed team. Whether you want to talk about our lead clinical long-acting HIV therapy candidate, TMB-365/TMB-380 or just say hello, we are here and excited to connect!

We are also honored to be presenting at this year's conference. Dr. Jimmy Chang, CEO of TaiMed Biologics, will deliver our Company Presentation on Thursday, July 16 from 1:30–1:45 PM TST at Booth 913.

Dr. Jing-Yi Huang, Senior Director of Research & Development, will present "A TMB-365-Based CD4-Targeted ADC Platform for HIV Functional Cure and Precision Immune Therapies" as part of Special Forum-1: Next Generation ADCs, on Thursday, July 16 from 11:00–11:15 AM TST in Room 403.

 
Back